• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁死亡相关基因特征可准确预测透明细胞肾细胞癌患者的生存结局。

Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma.

作者信息

Chang Kaili, Yuan Chong, Liu Xueguang

机构信息

Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

出版信息

Front Oncol. 2021 Apr 30;11:649347. doi: 10.3389/fonc.2021.649347. eCollection 2021.

DOI:10.3389/fonc.2021.649347
PMID:33996565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8120155/
Abstract

As a type of regulated cell death induced by Ras selective lethal (RSL) compounds such as erasti, ferroptosis is characterized by iron-dependent lipid peroxide accumulation to lethal levels. At present, little is known about the role of ferroptosis-related genes in clear-cell renal cell carcinoma (ccRCC). In the present study, the expression data of ferroptosis-related genes in ccRCC were obtained from the Cancer Genome Atlas (TCGA), and COX regression analysis was performed to construct a risk model of ferroptosis prognostic signature. The GEO database was used to verify the accuracy of the model. The following findings were made: the results reveal that the prognostic signature constructed by 11 ferroptosis genes (CARS, CD44, DPP4, GCLC, HMGCR, HSPB1, NCOA4, SAT1, PHKG2, GOT1, HMOX1) was significantly related to the overall survival (OS) of ccRCC patients based on the lowest Akaike information criterion (AIC); multivariate analysis indicates that ferroptosis-related gene prognostic signature was an independent prognostic factor in ccRCC patients; the calibration curve and c-index value (0.77) demonstrate that the nomogram with the signature could predict the survival of ccRCC patients; and enrichment analysis shows that the high-risk group were enriched in humoral immunity and receptor interaction pathways. The aforementioned findings indicate that the ferroptosis-related gene signature can accurately predict the prognosis of ccRCC patients and provide valuable insights for individualized treatment.

摘要

作为一种由如erasti等Ras选择性致死(RSL)化合物诱导的程序性细胞死亡,铁死亡的特征是铁依赖性脂质过氧化物积累至致死水平。目前,关于铁死亡相关基因在透明细胞肾细胞癌(ccRCC)中的作用知之甚少。在本研究中,从癌症基因组图谱(TCGA)获取ccRCC中铁死亡相关基因的表达数据,并进行COX回归分析以构建铁死亡预后特征的风险模型。利用GEO数据库验证该模型的准确性。得到以下结果:结果显示,基于最低赤池信息准则(AIC),由11个铁死亡基因(CARS、CD44、DPP4、GCLC、HMGCR、HSPB1、NCOA4、SAT1、PHKG2、GOT1、HMOX1)构建的预后特征与ccRCC患者的总生存期(OS)显著相关;多因素分析表明,铁死亡相关基因预后特征是ccRCC患者的独立预后因素;校准曲线和c指数值(0.77)表明,带有该特征的列线图可预测ccRCC患者的生存情况;富集分析显示,高危组在体液免疫和受体相互作用途径中富集。上述结果表明,铁死亡相关基因特征可准确预测ccRCC患者的预后,并为个体化治疗提供有价值的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c4f/8120155/7ceced139907/fonc-11-649347-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c4f/8120155/68a34005f977/fonc-11-649347-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c4f/8120155/93a3a24b8802/fonc-11-649347-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c4f/8120155/4b5e7f9af12b/fonc-11-649347-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c4f/8120155/9c174642eae2/fonc-11-649347-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c4f/8120155/1b6099d1e3cf/fonc-11-649347-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c4f/8120155/335d2bc8b6a8/fonc-11-649347-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c4f/8120155/73b1ad3d10ba/fonc-11-649347-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c4f/8120155/7ceced139907/fonc-11-649347-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c4f/8120155/68a34005f977/fonc-11-649347-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c4f/8120155/93a3a24b8802/fonc-11-649347-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c4f/8120155/4b5e7f9af12b/fonc-11-649347-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c4f/8120155/9c174642eae2/fonc-11-649347-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c4f/8120155/1b6099d1e3cf/fonc-11-649347-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c4f/8120155/335d2bc8b6a8/fonc-11-649347-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c4f/8120155/73b1ad3d10ba/fonc-11-649347-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c4f/8120155/7ceced139907/fonc-11-649347-g008.jpg

相似文献

1
Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma.铁死亡相关基因特征可准确预测透明细胞肾细胞癌患者的生存结局。
Front Oncol. 2021 Apr 30;11:649347. doi: 10.3389/fonc.2021.649347. eCollection 2021.
2
A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma.一种新型铁死亡相关的 12 基因标志物可预测透明细胞肾细胞癌的临床预后并揭示其免疫相关性。
BMC Cancer. 2021 Jul 19;21(1):831. doi: 10.1186/s12885-021-08559-0.
3
Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.基于铁死亡相关基因特征预测透明细胞肾细胞癌患者的总生存期。
World J Surg Oncol. 2022 Apr 14;20(1):120. doi: 10.1186/s12957-022-02555-9.
4
Ferroptosis-Related Gene-Based Prognostic Model and Immune Infiltration in Clear Cell Renal Cell Carcinoma.基于铁死亡相关基因的肾透明细胞癌预后模型及免疫浸润
Front Genet. 2021 Jun 9;12:650416. doi: 10.3389/fgene.2021.650416. eCollection 2021.
5
Comprehensive analysis of new prognostic signature based on ferroptosis-related genes in clear cell renal cell carcinoma.基于铁死亡相关基因的透明细胞肾细胞癌新预后标志物的综合分析。
Aging (Albany NY). 2021 Aug 9;13(15):19789-19804. doi: 10.18632/aging.203390.
6
Construction of A Novel Ferroptosis-related Prognostic Risk Signature for Survival Prediction in Clear Cell Renal Cell Carcinoma Patients.构建新型铁死亡相关预后风险模型预测透明细胞肾细胞癌患者的生存情况。
Urol J. 2022 May 22;19(4):289-299. doi: 10.22037/uj.v19i.6999.
7
Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.一种用于预测透明细胞肾细胞癌患者生存结局和免疫微环境的铁死亡相关长链非编码RNA(FRlncRNA)特征的鉴定与验证
Front Genet. 2022 Mar 8;13:787884. doi: 10.3389/fgene.2022.787884. eCollection 2022.
8
Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.与肿瘤免疫浸润相关的铁死亡相关长链非编码RNA特征分析及在肾透明细胞癌中的实验验证
Int J Gen Med. 2022 Mar 19;15:3215-3235. doi: 10.2147/IJGM.S354682. eCollection 2022.
9
Construction and validation of a ferroptosis-related long noncoding RNA signature in clear cell renal cell carcinoma.透明细胞肾细胞癌中铁死亡相关长链非编码RNA特征的构建与验证
Cancer Cell Int. 2022 Sep 14;22(1):283. doi: 10.1186/s12935-022-02700-0.
10
Accurate prognostic prediction for patients with clear cell renal cell carcinoma using a ferroptosis-related long non-coding RNA risk model.基于铁死亡相关长非编码 RNA 风险模型对透明细胞肾细胞癌患者进行准确预后预测。
Cancer Biomark. 2023;37(2):95-107. doi: 10.3233/CBM-210445.

引用本文的文献

1
Transcriptional activation of PHKG2 by TP53 promotes ferroptosis through nuclear export of NRF2 in head and neck squamous cell carcinoma.TP53对PHKG2的转录激活通过NRF2的核输出促进头颈部鳞状细胞癌中的铁死亡。
Cell Death Dis. 2025 Aug 30;16(1):662. doi: 10.1038/s41419-025-07985-3.
2
Dysregulation of ubiquitination modification in renal cell carcinoma.肾细胞癌中泛素化修饰的失调
Front Genet. 2024 Dec 19;15:1453191. doi: 10.3389/fgene.2024.1453191. eCollection 2024.
3
Machine Learning and Experimental Validation Identified Ferroptosis Signature and Innovative Biomarkers (ESR1 and GSTZ1) in Liver Fibrosis.

本文引用的文献

1
Identification of an RNA binding protein-related gene signature in hepatocellular carcinoma patients.鉴定肝癌患者中与 RNA 结合蛋白相关的基因特征。
Mol Med. 2020 Dec 9;26(1):125. doi: 10.1186/s10020-020-00252-5.
2
The critical role of BAP1 mutation in the prognosis and treatment selection of kidney renal clear cell carcinoma.BAP1突变在肾透明细胞癌预后及治疗选择中的关键作用
Transl Androl Urol. 2020 Aug;9(4):1725-1734. doi: 10.21037/tau-20-1079.
3
A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma.
机器学习与实验验证确定了肝纤维化中的铁死亡特征及创新生物标志物(ESR1和GSTZ1)
J Inflamm Res. 2024 Dec 4;17:10313-10332. doi: 10.2147/JIR.S490258. eCollection 2024.
4
Molecular signature of immune-related new survival predictions for subtype of renal cell carcinomas.肾细胞癌亚型免疫相关新生存预测的分子特征
Transl Androl Urol. 2024 Oct 31;13(10):2180-2193. doi: 10.21037/tau-24-225. Epub 2024 Oct 28.
5
Construction of a 12-Gene Prognostic Risk Model and Tumor Immune Microenvironment Analysis Based on the Clear Cell Renal Cell Carcinoma Model.基于透明细胞肾细胞癌模型构建12基因预后风险模型及肿瘤免疫微环境分析
Cancer Control. 2024 Jan-Dec;31:10732748241272713. doi: 10.1177/10732748241272713.
6
A ferroptosis-related signature predicts the clinical diagnosis and prognosis, and associates with the immune microenvironment of lung cancer.一种铁死亡相关特征可预测肺癌的临床诊断和预后,并与肺癌的免疫微环境相关。
Discov Oncol. 2024 May 14;15(1):163. doi: 10.1007/s12672-024-01032-x.
7
Ferritinophagy: A novel insight into the double-edged sword in ferritinophagy-ferroptosis axis and human diseases.铁蛋白自噬:铁蛋白自噬-铁死亡轴的双刃剑作用及人类疾病的新视角。
Cell Prolif. 2024 Jul;57(7):e13621. doi: 10.1111/cpr.13621. Epub 2024 Feb 23.
8
Microbial gene expression analysis of healthy and cancerous esophagus uncovers bacterial biomarkers of clinical outcomes.健康与癌性食管的微生物基因表达分析揭示了临床结局的细菌生物标志物。
ISME Commun. 2023 Dec 5;3(1):128. doi: 10.1038/s43705-023-00338-1.
9
Development and validation of a novel anoikis-related gene signature in clear cell renal cell carcinoma.一种新型的与失巢凋亡相关的基因特征在透明细胞肾细胞癌中的开发与验证
Front Oncol. 2023 Oct 26;13:1211103. doi: 10.3389/fonc.2023.1211103. eCollection 2023.
10
Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma.鉴定和验证与铁死亡相关的标志物,用于预测嗜铬细胞瘤肾细胞癌患者的预后和肿瘤微环境。
BMC Cancer. 2023 Nov 8;23(1):1079. doi: 10.1186/s12885-023-11589-5.
新型铁死亡相关基因签名可预测肝细胞癌患者的总生存期。
Int J Biol Sci. 2020 Jul 6;16(13):2430-2441. doi: 10.7150/ijbs.45050. eCollection 2020.
4
A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma.基于铁死亡相关基因的新型生存模型用于预测透明细胞肾细胞癌的预后。
Aging (Albany NY). 2020 Jul 20;12(14):14933-14948. doi: 10.18632/aging.103553.
5
Emerging Mechanisms and Disease Relevance of Ferroptosis.铁死亡的新兴机制及其与疾病的相关性
Trends Cell Biol. 2020 Jun;30(6):478-490. doi: 10.1016/j.tcb.2020.02.009. Epub 2020 Mar 21.
6
Ferroptosis: Final destination for cancer?铁死亡:癌症的最终归宿?
Cell Prolif. 2020 Mar;53(3):e12761. doi: 10.1111/cpr.12761. Epub 2020 Feb 25.
7
Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.一线抗PD-1/PD-L1药物与舒尼替尼治疗肉瘤样肾细胞癌患者的疗效比较:一项系统评价和荟萃分析
Cancers (Basel). 2020 Feb 10;12(2):408. doi: 10.3390/cancers12020408.
8
ACAT1 and Metabolism-Related Pathways Are Essential for the Progression of Clear Cell Renal Cell Carcinoma (ccRCC), as Determined by Co-expression Network Analysis.共表达网络分析表明,ACAT1与代谢相关通路对透明细胞肾细胞癌(ccRCC)进展至关重要。
Front Oncol. 2019 Oct 9;9:957. doi: 10.3389/fonc.2019.00957. eCollection 2019.
9
Recent Progress in Ferroptosis Inducers for Cancer Therapy.铁死亡诱导剂在癌症治疗中的最新进展。
Adv Mater. 2019 Dec;31(51):e1904197. doi: 10.1002/adma.201904197. Epub 2019 Oct 8.
10
Molecular mechanisms of ferroptosis and its role in cancer therapy.铁死亡的分子机制及其在癌症治疗中的作用。
J Cell Mol Med. 2019 Aug;23(8):4900-4912. doi: 10.1111/jcmm.14511. Epub 2019 Jun 24.